Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-12 to 2024-09-13
Current total value of award: $7953.16
Description: 4565781622!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML